Conference Agenda

Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).

 
Only Sessions at Location/Venue 
 
 
Session Overview
Location: ETH E27
D-BSSE, ETH, 84 seats
Date: Monday, 25/Aug/2025
11:30am
-
1:00pm
Causal inference - dealing with bias
Location: ETH E27
 

Proximal indirect comparison

Zehao Su, Helene Rytgaard, Henrik Ravn, Frank Eriksson



Selection bias of cause-specific hazard ratios: the impact of competing events

Mari Brathovde, Morten Valberg, Hein Putter, Richard A.J. Post



qbaconfound: A flexible Monte Carlo probabilistic bias analysis to unmeasured confounding

Emily Kawabata, Chin Yang Shapland, Tom Palmer, David Carslake, Kate Tilling, Rachael Hughes



Selection bias due to omitting interactions from inverse probability weighting

Liping Wen, Kate Tilling, Rosie Cornish, Rachael Hughes, Apostolos Gkatzionis



External reproduction of a proxy-based causal model estimating average survival effects of sequential vs concurrent chemo-radiotherapy in stage III NSCLC

Charlie Cunniffe, Wouter van Amsterdam, Matthew Sperrin, Rajesh Ranganath, Fiona Blackhall, Gareth Price

2:00pm
-
3:30pm
Meta-analysis 1
Location: ETH E27
 

Precision Of Treatment Hierarchy: A Metric for Quantifying Certainty in Treatment Hierarchies from Network Meta-Analysis

Augustine Wigle, Audrey Béliveau, Georgia Salanti, Gerta Rücker, Guido Schwarzer, Dimitris Mavridis, Adriani Nikolakopoulou



Extending P-Scores for Ranking Diagnostic Tests in Network Meta-Analysis

Sofia Tsokani, Fani Apostolidou-Kiouti, Adriani Nikolakopoulou, Areti-Angeliki Veroniki, Anna-Bettina Haidich, Dimitris Mavridis



Resolving conflicting treatment hierarchies across multiple outcomes in multivariate network meta-analysis

Theodoros Evrenoglou, Anna Chaimani, Guido Schwarzer



A novel approach for modelling components of complex interventions in network meta-analysis

Tianqi Yu, Anna Chaimani



The impact of using different random effects models in meta-analysis

KANELLA PANAGIOTOPOULOU, SOODABEH BEHBOODI, JENNIFER ZEITLIN, ANNA CHAIMANI

4:00pm
-
5:30pm
Bayesian methods 1
Location: ETH E27
 

A Bayesian model for surrogate endpoint evaluation in mixed biomarker patient populations

Lorna Sophie Kate Wheaton, Stephanie Hubbard, Sandro Gsteiger, Sylwia Bujkiewicz



Extending Bayesian Causal Forests for Longitudinal Data Analysis: A Case Study in Multiple Sclerosis

Emma Prevot, Thomas E. Nichols, Chris Holmes, Habib Ganjgahi



A Bayesian framework for measuring the information cost of interim decisions in group sequential trials

Gianmarco Caruso, William F. Rosenberger, Pavel Mozgunov, Nancy Flournoy



Bayesian semiparametric modelling of biomarker variability in joint models for longitudinal and survival data

Sida Chen, Marco Palma, Barrett Jessica



Bayesian analysis of the causal reference-based model for missing data in clinical trials

Brendah Nansereko, Marcel Wolbers, James Carpenter, Jonathan Bartlett

Date: Tuesday, 26/Aug/2025
9:15am
-
10:45am
Infectious disease modelling
Location: ETH E27
 

Flexible parametric additive hazards regression for modeling excess mortality in pandemics

Liesbeth C de Wreede, Marina T Dietrich, Ilaria Prosepe, Hein Putter, Mar Rodriguez-Girondo



Parameter Estimation in Compartmental Epidemic Models with Heterogeneity in Susceptibility

Yuwen Ding, Jacco Wallinga, Hein Putter



Unobserved intermediate events in multi-state models in a pandemic setting

Ilaria Prosepe, Hein Putter, Mar Rodriguez-Girondo, Liesbeth C. de Wreede



Controlled vaccine efficacy using a joint model for sparse immunological data and time-to-disease.

Grigorios Papageorgiou, Silvia Noirjean, Toufik Zahaf, Andrea Callegaro



Infectious Disease Estimands That Are Insensitive to Interference

Mats Stensrud

11:30am
-
1:00pm
Meta-analysis 2
Location: ETH E27
 

How to quantify between-study heterogeneity in single-arm evidence synthesis

Ulrike Held, Lea Bührer, Beatrix Latal, Stefania Iaquinto



Bayesian random-effects meta-analysis with empirical heterogeneity priors for HTA applications in the situation of very few studies

Ralf Bender, Jona Lilienthal, Sibylle Sturtz, Christian Röver, Tim Friede



Assessing inconsistency in flexible meta-regression using network meta analysis

Marc Angelo Parsons, Andrea Benedetti, Russell Steele



Illuminating the Assumptions of Meta-Regression in Treatment Networks

Nana-adjoa Kwarteng, Theodoros Evrenoglou, Adriani Nikolakopoulou



Transitivity in Network Meta-Analysis: A Formal Framework and Practical Implications

Noosheen Rajabzadeh Tahmasebi, Ian White, Georgia Salanti, Efthimiou Orestis, Adriani Nikolakopoulou

Date: Wednesday, 27/Aug/2025
9:00am
-
10:30am
Prediction / prognostic modelling 3
Location: ETH E27
 

Predicting Prediction Performance

Max Westphal, Rieke Alpers



Predictive modelling with block missingness

Viktor Racinskij, Robin Mitra, Chris Harbron, Niels Hagenbuch



Lifestyle Predictors of All-Cause Mortality: Enhancing Risk Models Beyond Traditional Biomarkers

Yuhe Wang, Cameron Razieh, Thomas Yates



Development and validation of the Options model, a clinical prediction model predicting risk of emergency caesarean births in nulliparous women

Alexandra Hunt



Optimizing Dynamic Predictions from Joint Models using Super Learning

Dimitris Rizopoulos, Jeremy M.G. Taylor

2:00pm
-
3:30pm
Innovation in oncology dose escalation trials and beyond
Location: ETH E27
 

Declaring Doses as Safe in Ongoing Oncology Dose-Escalation Trials: Are They Truly Safe? A Critical Assessment of Safety Criteria

Stefan Englert, Thomas J. Prior, Anirban Mitra, Busola Sanusi, Liangcai Zhang, Lilla Di Scala



Guiding Phase I Dose Escalation for Modern Oncology Therapies: Tackling (Informative) Dropout with Bayesian Multi-Cycle Time-to-Event Models

Lukas Andreas Widmer, Sebastian Weber



Potential Responses and the Order of Patient Inclusion in Early-Phase Sequential Trials.

Meliha Akouba, Matthieu Clertant, Alexia Iasonos, John O'quigley



How best to allocate backfill patients in dose-finding oncology trials: a methodological review & simulation studies assessing best performance

Elli Bourmpaki, Helen Barnett, Oliver Boix, Hakim-Moulay Dehbi



Dose optimisation in early phase oncology trials - backfill and expansion cohorts

James Willard, Thomas Jaki, Burak Kürsad Günhan, Christina Habermehl, Anja Victor, Pavel Mozgunov

4:00pm
-
5:30pm
Prediction / prognostic modelling 4
Location: ETH E27
 

Adapting existing sample size calculations for developing risk prediction models to control for model stability

Gareth Ambler, Menelaos Pavlou, Rumana Z Omar



Optimal Methods for Handling Continuous Predictors in Clinical Prediction Model Development: Balancing Flexibility and Stability

Phichayut Phinyo, Pakpoom Wongyikul, Noraworn Jirattikanwong, Natthanaphop Isaradech, Wachiranun Sirikul, Wuttipat Kiratipaisarl, Noppadon Seesuwan, Suppachai Lawanaskol



Do Stable Performance Metrics Guarantee Stable Model Predictions?

Natthanaphop Isaradech, Phichayut Phinyo, Wuttipat Kiratipaisarl, Pakpoom Wongyikul, Noraworn Jirattikanwong, Wachiranun Sirikul



The Imbalance Dilemma: Can Class Imbalance Corrections Stabilize Clinical Prediction Models?

Wachiranun Sirikul, Natthanaphop Isaradech, Wuttipat Kiratipaisarl, Phichayut Phinyo, Pakpoom Wongyeekul, Noraworn Jirattikanwong



Prediction with Logistic Regression in Binary Class Imbalance: comparing re-sampling techniques with threshold probability assignment under varying predictive covariates

Henk van der Pol, Ragnhild Sørum Falk, Marta Fiocco, Arnoldo Frigessi, Euloge Clovis Kenne Pagui


 
Contact and Legal Notice · Contact Address:
Privacy Statement · Conference: ISCB46
Conference Software: ConfTool Pro 2.6.154+TC
© 2001–2025 by Dr. H. Weinreich, Hamburg, Germany